anti-Cytokeratin 6 antibody product blogThe Cytokeratin 6 n/a (Catalog #MBS2534441) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Cytokeratin 6 Monoclonal Antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s Cytokeratin 6 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB).
WB: 1:500-1:2000. Researchers should empirically determine the suitability of the Cytokeratin 6 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Cytokeratin 6 Monoclonal Antibody with the following immunoassay(s):
Western Blot (WB) (Western Blot analysis of 1) Hela, 2) HepG2 cells using Cytokeratin 6 Monoclonal Antibody at dilution of 1:2000.)
Immunohistochemistry (IHC) (Immunohistochemistry of paraffin-embedded Human breast cancer tissue using Cytokeratin 6 Monoclonal Antibody at dilution of 1:200.)
Immunofluorescence (IF) (Immunofluorescence analysis of Human breast cancer tissue using Cytokeratin 6 Monoclonal Antibody at dilution of 1:200.)
Immunogen: Synthetic Peptide
Buffer: PBS, pH 7.4, containing 0.02% sodium azide as Preservative and 50% Glycerol. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Cytokeratin 6 are readily searchable from our website. Different antibodies against the same target such as Cytokeratin 6 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.